Skip to main content
PMC home page
Gut logoLink to Gut
. 1980 Nov;21(11):965–969. doi: 10.1136/gut.21.11.965

Treatment of alcohol-related liver disease with (+)-cyanidanol-3: a randomised double-blind trial.

J C Colman, M Y Morgan, P J Scheuer, S Sherlock
PMCID: PMC1419277  PMID: 6108901

Abstract

A randomised double-blind trial of (+)-cyanidanol-3(Catechin), 2 g/day versus placebo, was carried out in 40 patients with pre-cirrhotic alcohol-related liver disease over a three month period. Twenty received the active drug and 20 placebo; one non-compliant patient in the treatment group was withdrawn. Forty-one per cent (16/39) abstained from alcohol and showed significant improvements (P < 0.005) in mean values for serum aspartate transaminase, serum gamma glutamyl transpeptidase, and mean corpuscular volume. Ten of the 16 showed overall histological improvement on liver biopsy. Fifty-nine pr cent (23/39) continued to drink, though significantly reducing their mean daily alcohol intake (P < 0.001). No significant changes occurred in this group in mean serum enzyme values, though the mean value for mean corpuscular volume improved significantly (P < 0.01) and 16 of the 23 showed overall histological improvement. Changes occurred irrespective of treatment with Catechin which suggests that, over a three month period, this drug did not influence the course of alcohol-related liver disease.

Full text

PDF
969

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cetta G., Gerzeli G., Quartieri A., Castellani A. A. Protective effect of flavonoids on the collagen of lathyritic rats. Experientia. 1971 Sep 15;27(9):1046–1048. doi: 10.1007/BF02138872. [DOI] [PubMed] [Google Scholar]
  2. Das N. P., Sothy S. P. Studies on flavonoid metabolism. Biliary and urinary excretion of metabolites of (+)-(U- 14 C)catechin. Biochem J. 1971 Nov;125(2):417–423. doi: 10.1042/bj1250417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Gajdos A., Gajdos-Tërök M., Horn R. The effect of (+)-catechin on the hepatic level of ATP and the lipid content of liver during experimental steatosis. Biochem Pharmacol. 1972 Feb 15;21(4):594–600. doi: 10.1016/0006-2952(72)90338-3. [DOI] [PubMed] [Google Scholar]
  4. Galizzi J., Morgan M. Y., Chitranukroh A., Sherlock S. The detection of minimal alcoholic liver disease by three methods. Scand J Gastroenterol. 1978;13(7):827–831. doi: 10.3109/00365527809182198. [DOI] [PubMed] [Google Scholar]
  5. Geokas M. C., Rinderknecht H. Plasma arylsulfatase and beta-glucuronidase in acute alcoholism. Clin Chim Acta. 1973 Jun 14;46(1):27–32. doi: 10.1016/0009-8981(73)90098-3. [DOI] [PubMed] [Google Scholar]
  6. LIEBER C. S., SCHMID R. The effect of ethanol on fatty acid metabolism; stimulation of hepatic fatty acid synthesis in vitro. J Clin Invest. 1961 Feb;40:394–399. doi: 10.1172/JCI104266. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Lieber C. S. Liver adaptation and injury in alcoholism. N Engl J Med. 1973 Feb 15;288(7):356–362. doi: 10.1056/NEJM197302152880710. [DOI] [PubMed] [Google Scholar]
  8. Lieber C. S., Rubin E. Alcoholic fatty liver in man on a high protein and low fat diet. Am J Med. 1968 Feb;44(2):200–206. doi: 10.1016/0002-9343(68)90151-4. [DOI] [PubMed] [Google Scholar]
  9. Lieber C. S., Spritz N., DeCarli L. M. Fatty liver produced by dietary deficiencies: its pathogenesis and potentiation by ethanol. J Lipid Res. 1969 May;10(3):283–287. [PubMed] [Google Scholar]
  10. Lieber C. S., Spritz N., DeCarli L. M. Role of dietary, adipose, and endogenously synthesized fatty acids in the pathogenesis of the alcoholic fatty liver. J Clin Invest. 1966 Jan;45(1):51–62. doi: 10.1172/JCI105323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lieber C. S., Spritz N. Effects of prolonged ethanol intake in man: role of dietary adipose, and endogenously synthesized fatty acids in the pathogenesis of the alcoholic fatty liver. J Clin Invest. 1966 Sep;45(9):1400–1411. doi: 10.1172/JCI105448. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Mendenhall C. L. Origin of hepatic triglyceride fatty acids: quantitative estimation of the relative contributions of linoleic acid by diet and adipose tissue in normal and ethanol-fed rats. J Lipid Res. 1972 Mar;13(2):177–183. [PubMed] [Google Scholar]
  13. NIKKILAE E. A., OJALA K. ROLE OF HEPATIC L-ALPHA-GLYCEROPHOSPHATE AND TRIGLYCERIDE SYNTHESIS IN PRODUCTION OF FATTY LIVER BY ETHANOL. Proc Soc Exp Biol Med. 1963 Aug-Sep;113:814–817. doi: 10.3181/00379727-113-28499. [DOI] [PubMed] [Google Scholar]
  14. Rubin E., Lieber C. S. Alcohol-induced hepatic injury in nonalcoholic volunteers. N Engl J Med. 1968 Apr 18;278(16):869–876. doi: 10.1056/NEJM196804182781602. [DOI] [PubMed] [Google Scholar]
  15. Van Caneghem P. Influence of some hydrosoluble substances with vitamin P activity on the fragility of lysosomes in vitro. Biochem Pharmacol. 1972 Jun 1;21(11):1543–1548. doi: 10.1016/0006-2952(72)90303-6. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES